Analysis: House Ways & Means Health Subcommittee advances its surprise-bill draft legislation
Although the House Energy and Commerce Health Subcommittee approved its surprise bill legislation last week, there are other factors at play in the coming weeks that could delay further action on it.
Analysis: Deadline passes for NC state employee Medicare reference pricing contract
An overview of the North Carolina Clear Pricing Project, its contract deadline passing and how North Carolina’s hospitals have reacted to the CPP.
Analysis: Results from Medicare’s mandatory joint replacement bundle
A discussion of the results of the Medicare Comprehensive Care for Joint Replacement program and three keys to implementing a successful PAC management program.
Analysis: 6 strategies of successful ACOs revealed in OIG study
The six strategies used by successful accountable care organizations are discussed in a review of a study of successful ACOs, released by the Office of the Inspector General last week.
The price of precision medicine: 3 ways for health plans to manage genetic-testing costs
With spending on genetic testing expected to grow significantly, health plans can use three steps to get a handle on costs.
Top 5 episode-analytics questions answered
As healthcare providers continue to move toward value-based care models, data and analytics will continue to play an important role. In 2017 alone, U.S. hospitals cared for over 36.5 million admissions. As this number continues to grow, providers will need to understand their patients not only as they pass through their own care journey, but…
2 states take the lead in implementing innovative healthcare reforms
Washington and Colorado are seeking to funnel noteworthy innovations in healthcare reform, including a public option, through their Medicaid infrastructures.
Analysis: New mandatory radiation therapy payment model
Details about the new five-year mandatory radiation therapy model released by CMS the week of July 8 are reviewed.
Analysis: Administration’s plans on drug pricing faced recent multiple setbacks
In the face of recent, multiple setbacks on the Trump administration’s proposals for drug pricing, the administration could move aggressively forward on its anticipated International Pricing Index Model for Part B drugs proposal.
Analysis: Survey results show health systems prepared to take risk
Results of a recent HFMA/Navigant survey show providers are prepared to increase their level of payment risk. HFMA’s Chad Mulvany provides insight on what these results indicate.